212 related articles for article (PubMed ID: 29973584)
21. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
[TBL] [Abstract][Full Text] [Related]
22. A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer.
Shen S; Li Z; Jiang Y; Duan W; Li H; Du S; Esteller M; Shen H; Hu Z; Zhao Y; Christiani DC; Chen F
Am J Respir Crit Care Med; 2023 Aug; 208(3):280-289. PubMed ID: 37167549
[No Abstract] [Full Text] [Related]
23. Somatic and Germline
Sherborne AL; Lavergne V; Yu K; Lee L; Davidson PR; Mazor T; Smirnoff IV; Horvai AE; Loh M; DuBois SG; Goldsby RE; Neglia JP; Hammond S; Robison LL; Wustrack R; Costello JF; Nakamura AO; Shannon KM; Bhatia S; Nakamura JL
Clin Cancer Res; 2017 Apr; 23(7):1852-1861. PubMed ID: 27683180
[No Abstract] [Full Text] [Related]
24. Pathogenic Germline Variants in 10,389 Adult Cancers.
Huang KL; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N; Scott AD; Krassowski M; Cherniack AD; Houlahan KE; Jayasinghe R; Wang LB; Zhou DC; Liu D; Cao S; Kim YW; Koire A; McMichael JF; Hucthagowder V; Kim TB; Hahn A; Wang C; McLellan MD; Al-Mulla F; Johnson KJ; ; Lichtarge O; Boutros PC; Raphael B; Lazar AJ; Zhang W; Wendl MC; Govindan R; Jain S; Wheeler D; Kulkarni S; Dipersio JF; Reimand J; Meric-Bernstam F; Chen K; Shmulevich I; Plon SE; Chen F; Ding L
Cell; 2018 Apr; 173(2):355-370.e14. PubMed ID: 29625052
[TBL] [Abstract][Full Text] [Related]
25. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
26. Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
Yu Y; Hu H; Chen JS; Hu F; Fowler J; Scheet P; Zhao H; Huff CD
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2247-2254. PubMed ID: 29317335
[TBL] [Abstract][Full Text] [Related]
27. Frequency of germline genomic homozygosity associated with cancer cases.
Assié G; LaFramboise T; Platzer P; Eng C
JAMA; 2008 Mar; 299(12):1437-45. PubMed ID: 18364486
[TBL] [Abstract][Full Text] [Related]
28. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
29. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
[TBL] [Abstract][Full Text] [Related]
30. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
31. Common Germline Risk Variants Impact Somatic Alterations and Clinical Features across Cancers.
Namba S; Saito Y; Kogure Y; Masuda T; Bondy ML; Gharahkhani P; Gockel I; Heider D; Hillmer A; Jankowski J; MacGregor S; Maj C; Melin B; Ostrom QT; Palles C; Schumacher J; Tomlinson I; Whiteman DC; Okada Y; Kataoka K
Cancer Res; 2023 Jan; 83(1):20-27. PubMed ID: 36286845
[TBL] [Abstract][Full Text] [Related]
32. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
[TBL] [Abstract][Full Text] [Related]
33. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
34. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.
Gala MK; Mizukami Y; Le LP; Moriichi K; Austin T; Yamamoto M; Lauwers GY; Bardeesy N; Chung DC
Gastroenterology; 2014 Feb; 146(2):520-9. PubMed ID: 24512911
[TBL] [Abstract][Full Text] [Related]
35. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
Chen J; Li Y; Wu J; Liu Y; Kang S
Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
[TBL] [Abstract][Full Text] [Related]
36. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Toledo RA; Qin Y; Cheng ZM; Gao Q; Iwata S; Silva GM; Prasad ML; Ocal IT; Rao S; Aronin N; Barontini M; Bruder J; Reddick RL; Chen Y; Aguiar RC; Dahia PL
Clin Cancer Res; 2016 May; 22(9):2301-10. PubMed ID: 26700204
[TBL] [Abstract][Full Text] [Related]
37. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
38. De-novo "germline second hit" loss-of-heterozygosity RBP3 deletion mutation causing recessive high myopia.
Gombosh M; Yogev Y; Hadar N; Proskorovski-Ohayon R; Aharoni S; Gradstein L; Birk OS
Clin Genet; 2023 Nov; 104(5):571-576. PubMed ID: 37308324
[TBL] [Abstract][Full Text] [Related]
39. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
[TBL] [Abstract][Full Text] [Related]
40. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
Sorscher S; Ansley K; Delaney SD; Ramkissoon S
Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
